Ethics Review of Biomedical Research in Uzbekistan: Policy and Program Gaps

Area of Science:

• Health Research Ethics
• Human Subject Protection
• Clinical Trials Oversight

Background:

• The national health research ethics review system in Uzbekistan is centralized.
• Current systems have identified gaps in protecting human research subjects.
• Clinical Drug Trials (CDTs) are conducted without adequate ethical review at institutional levels.

Purpose of the Study:

• To describe the current health research ethics review system in Uzbekistan.
• To identify policy and program deficiencies.
• To propose recommendations for improving human subject protection.

Main Methods:

• Descriptive analysis of the existing national health research ethics review framework.
• Identification of gaps in policy and program implementation.
• Review of the roles and effectiveness of the National Ethics Committee (NEC) and regional committees.

Main Results:

• The National Ethics Committee (NEC) is the sole national-level reviewer.
• Regional ethics committees show limited evidence of effective operation.
• Medical institutes and research centers lack research ethics review, despite conducting clinical drug trials (CDTs).
• Absence of a national policy for ethical review of non-clinical trials.

Conclusions:

• The current system has significant gaps in the ethical review process for human research subjects.
• Establishment of institutional review boards (IRBs) at medical institutes and research centers is recommended.
• Capacity building at the national level is crucial for effective oversight and support of the entire research ethics review system.